Table 1 2016–2017 vaccine coverage in preterm infants and regional paediatric population (z-test)
Vaccine | Preterm cohort | Regional pediatric population | p | |
|---|---|---|---|---|
n/N | % (95%CI) | % | ||
DTaP-IPV-HBV-Hib 1 doses | 169/170 | 99.4 (96.3–100.0) | 99.0 | 0.878 |
DTaP-IPV-HBV-Hib 2 doses | 165/168 | 98.2 (94.5–99.5) | 94.8 | 0.069 |
DTaP-IPV-HBV-Hib 3 doses | 161/167 | 96.4 (92.0–98.5) | 95.2 | 0.583 |
PCV 1 doses | 167/170 | 98.2 (94.7–99.5) | 98.4 | > 0.99 |
PCV 2 doses | 160/168 | 95.2 (90.5–97.8) | 94.1 | 0.644 |
PCV 3 doses | 152/167 | 91.0 (85.4–94.7) | 93.6 | 0.228 |
Men C | 137/167 | 82.0 (75.2–87.4) | 83.2 | 0.765 |
MMR | 158/167 | 94.6 (89.7–97.3) | 94.2 | 0.951 |
Varicella | 158/167 | 94.6 (89.7–97.3) | 91.7 | 0.221 |